Phibro Animal Health Corporation (PAHC) financial statements (2021 and earlier)

Company profile

Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR
TEANECK, NJ 07666
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments75827956342912
Cash and cash equivalents26582956342912
Short-term investments492450    
Receivables147159136126124111114
Inventory, net of allowances, customer advances and progress billings194198178161168150143
Inventory194198178161168150143
Other current assets2927222118  
Other undisclosed current assets     2430
Total current assets:445466415364343314299
Noncurrent Assets
Property, plant and equipment145140130127127104109
Long-term investments and receivables     56
Long-term investments     56
Intangible assets, net (including goodwill)128757979815042
Goodwill53272724211313
Intangible assets, net (excluding goodwill)76475255603730
Deferred costs     45
Other noncurrent assets70454754593834
Deferred tax assets, net    03
Other undisclosed noncurrent assets     (22)(27)
Total noncurrent assets:343261256260268180173
TOTAL ASSETS:788727672623610493472
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities131142131110106131130
Accounts payable58735957606360
Accrued liabilities73687153464550
Employee-related liabilities     2221
Debt161313 (3)(3)(3)
Liability for uncertainty in income taxes    59 
Business combination, contingent consideration, liability     1
Other liabilities     1314
Other undisclosed current liabilities   60(40)(29)
Total current liabilities:147154143116109111112
Noncurrent Liabilities
Long-term debt and lease obligation, including:208218230242281284286
Long-term debt, excluding current maturities357967065693 
Capital lease obligations     0
Operating lease, liability17
Other undisclosed long-term debt and lease obligation(166)122160177212281286
Liabilities, other than long-term debt665051506112458
Accounts payable and accrued liabilities     8 
Deferred tax liabilities, net    19 
Liability for uncertainty in income taxes 78    
Liability, pension and other postretirement and postemployment benefits     31
Other liabilities66434450616658
Other undisclosed noncurrent liabilities14989626569(55) 
Total noncurrent liabilities:424356344356411352345
Total liabilities:571511487472520464457
Stockholders' equity
Stockholders' equity attributable to parent, including:217216185151903015
Additional paid in capital134133130124118118132
Accumulated other comprehensive loss(91)(86)(76)(55)(62)(52)(20)
Retained earnings (accumulated deficit)1741691328334(37)(97)
Other undisclosed stockholders' equity attributable to parent0000000
Total stockholders' equity:217216185151903015
TOTAL LIABILITIES AND EQUITY:788727672623610493472

Income statement (P&L) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues813828820764752749692
Cost of revenue
(Cost of Goods and Services Sold)
(556)(563)(553)(516)(512)(512)(484)
Gross profit:257265267248239236208
Operating expenses(193)(181)(168)(150)(153)(166)(158)
Other undisclosed operating income     1714
Operating income:64839998868864
Nonoperating income (expense)(2)010862
Foreign currency transaction gain (loss), before tax(2)010851
Interest and debt expense(2)(0)(1)(3)(0)(15)(53)
Income from continuing operations before equity method investments, income taxes:60839995937913
Other undisclosed loss from continuing operations before income taxes(11)(11)(11)(15)(16) (6)
Income from continuing operations before income taxes:4972888177796
Income tax expense (benefit)(11)(17)(23)(16)6(18)(9)
Net income (loss) available to common stockholders, diluted:385565658360(3)

Comprehensive Income ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):385565658360(3)
Comprehensive income (loss):385565658360(3)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(10)(10)(21)6(10)(32)(2)
Comprehensive income (loss), net of tax, attributable to parent:294544717329(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: